Safety of rituximab in the routine treatment of rheumatoid arthritis in Italy in patients refractory to anti-TNFa drugs: results from the observational retrospective-prospective RUBINO study. (2014). Reumatismo, 66(3), 224-232. https://doi.org/10.4081/reumatismo.2014.748